These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 23619358)

  • 1. Illuminating regeneration: noninvasive imaging of disease progression in muscular dystrophy.
    Levy JR; Campbell KP
    J Clin Invest; 2013 May; 123(5):1931-4. PubMed ID: 23619358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Assessment of disease activity in muscular dystrophies by noninvasive imaging.
    Maguire KK; Lim L; Speedy S; Rando TA
    J Clin Invest; 2013 May; 123(5):2298-305. PubMed ID: 23619364
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monitoring disease activity noninvasively in the
    Filareto A; Maguire-Nguyen K; Gan Q; Aldanondo G; Machado L; Chamberlain JS; Rando TA
    Proc Natl Acad Sci U S A; 2018 Jul; 115(30):7741-7746. PubMed ID: 29987034
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Direct effects of the pathogenic mutation on satellite cell function in muscular dystrophy.
    Morgan JE; Zammit PS
    Exp Cell Res; 2010 Nov; 316(18):3100-8. PubMed ID: 20546725
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Muscular dystrophy: from pathogenesis to strategy.
    Hsu YD
    Acta Neurol Taiwan; 2004 Jun; 13(2):50-8. PubMed ID: 15478675
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular imaging to target transplanted muscle progenitor cells.
    Gutpell K; McGirr R; Hoffman L
    J Vis Exp; 2013 Mar; (73):. PubMed ID: 23568004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differential expression of genes involved in the degeneration and regeneration pathways in mouse models for muscular dystrophies.
    Onofre-Oliveira PC; Santos AL; Martins PM; Ayub-Guerrieri D; Vainzof M
    Neuromolecular Med; 2012 Mar; 14(1):74-83. PubMed ID: 22362587
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mechanisms of muscle degeneration, regeneration, and repair in the muscular dystrophies.
    Wallace GQ; McNally EM
    Annu Rev Physiol; 2009; 71():37-57. PubMed ID: 18808326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Degeneration and regeneration of striated skeletal muscle fibers in Duchenne muscular dystrophy].
    Brasseur G; Onolfo JP; Copin H; Leperchey F; Barbet JP
    Morphologie; 1997 Mar; 81(252):9-13. PubMed ID: 9737904
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unacylated Ghrelin Enhances Satellite Cell Function and Relieves the Dystrophic Phenotype in Duchenne Muscular Dystrophy mdx Model.
    Reano S; Angelino E; Ferrara M; Malacarne V; Sustova H; Sabry O; Agosti E; Clerici S; Ruozi G; Zentilin L; Prodam F; Geuna S; Giacca M; Graziani A; Filigheddu N
    Stem Cells; 2017 Jul; 35(7):1733-1746. PubMed ID: 28436144
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Brief report: Blockade of Notch signaling in muscle stem cells causes muscular dystrophic phenotype and impaired muscle regeneration.
    Lin S; Shen H; Jin B; Gu Y; Chen Z; Cao C; Hu C; Keller C; Pear WS; Wu L
    Stem Cells; 2013 Apr; 31(4):823-8. PubMed ID: 23307608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide sustains long-term skeletal muscle regeneration by regulating fate of satellite cells via signaling pathways requiring Vangl2 and cyclic GMP.
    Buono R; Vantaggiato C; Pisa V; Azzoni E; Bassi MT; Brunelli S; Sciorati C; Clementi E
    Stem Cells; 2012 Feb; 30(2):197-209. PubMed ID: 22084027
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dystrophinopathies and related disorders.
    Cherin P
    Curr Opin Rheumatol; 1995 Nov; 7(6):475-85. PubMed ID: 8579967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Satellite potentials in electromyograms in patients with Duchenne progressive muscular atrophy].
    Rowińska-Marcińska K; Badurska B; Karwańska A
    Neurol Neurochir Pol; 1993; 27(2):163-73. PubMed ID: 8327035
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Perturbation of muscle metabolism in patients with muscular dystrophy in early or acute phase of disease: In vitro, high resolution NMR spectroscopy based analysis.
    Srivastava NK; Yadav R; Mukherjee S; Sinha N
    Clin Chim Acta; 2018 Mar; 478():171-181. PubMed ID: 29278724
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wasting mechanisms in muscular dystrophy.
    Shin J; Tajrishi MM; Ogura Y; Kumar A
    Int J Biochem Cell Biol; 2013 Oct; 45(10):2266-79. PubMed ID: 23669245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Silencing Nfix rescues muscular dystrophy by delaying muscle regeneration.
    Rossi G; Bonfanti C; Antonini S; Bastoni M; Monteverde S; Innocenzi A; Saclier M; Taglietti V; Messina G
    Nat Commun; 2017 Oct; 8(1):1055. PubMed ID: 29057908
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stem cell based therapies to treat muscular dystrophy.
    Price FD; Kuroda K; Rudnicki MA
    Biochim Biophys Acta; 2007 Feb; 1772(2):272-83. PubMed ID: 17034994
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Targeting muscle stem cell intrinsic defects to treat Duchenne muscular dystrophy.
    Dumont NA; Rudnicki MA
    NPJ Regen Med; 2016; 1():16006-. PubMed ID: 29188075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A reporter mouse for optical imaging of inflammation in mdx muscles.
    Martinez L; Ermolova NV; Ishikawa TO; Stout DB; Herschman HR; Spencer MJ
    Skelet Muscle; 2015; 5():15. PubMed ID: 25949789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.